期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
TLR2 and TLR4 polymorphisms influence m RNA and protein expression in colorectal cancer 被引量:9
1
作者 Marcela Alcantara Proenca Juliana Garcia de Oliveira +5 位作者 Aline Cristina Targa Cadamuro Maysa Succi Joao Gomes Netinho Eny Maria Goloni-Bertolo érika Cristina Pavarino Ana Elizabete Silva 《World Journal of Gastroenterology》 SCIE CAS 2015年第25期7730-7741,共12页
AIM: To evaluate the effect of promoter region polymorphisms of toll-like receptor(TLR)2-196 to-174 del and TLR4-1607T/C(rs10759932) on m RNA and protein expression in tumor tissue and of TLR4+896A/G(rs4986790) on col... AIM: To evaluate the effect of promoter region polymorphisms of toll-like receptor(TLR)2-196 to-174 del and TLR4-1607T/C(rs10759932) on m RNA and protein expression in tumor tissue and of TLR4+896A/G(rs4986790) on colorectal cancer(CRC) risk.METHODS: The TLR2-196 to-174 del polymorphism was investigated using allele-specific polymerase chain reaction(PCR) and the TLR4-1607T/C and TLR4+896A/G by PCR-restriction fragment length p o l y m o r p h i s m( R F L P). W e g e n o t y p e d 4 3 4 D N A samples from 194 CRC patients and 240 healthy individuals. The m RNA relative quantification(RQ) was performed in 40 tumor tissue samples by quantitative PCR Taq Man assay, using specific probes for TLR2 and TLR4 genes, and ACTB and GAPDH reference geneswere used as endogenous controls. Protein expression was analyzed by immunohistochemistry with specific primary antibodies.RESULTS: No association was found for TLR4-1607T/C and TLR4+896A/G by three statistical models(logadditive, dominant and recessive). However, based on dominant and log-additive models, the polymorphic variant TLR2-196 to-174 del was associated with increased CRC risk [dominant: odds ratio(OR) = 1.72, 95%CI: 1.03-2.89; P = 0.038 and log-additive: OR =1.59, 95%CI: 1.02-2.48; P = 0.039]. TLR2 m RNA expression was increased in tumor tissue(RQ = 2.36) when compared to adjacent normal tissue(RQ = 1; P < 0.0001), whereas the TLR4 m RNA showed a basal expression(RQ = 0.74 vs RQ = 1, P = 0.452). Immunohistochemistry analysis of TLR2 and TLR4 protein expression was concordant with the findings of m RNA expression. In addition, the TLR2-196 to-174 del variant carriers showed m RNA relative expression 2.19 times higher than wild-genotype carriers. The TLR2 protein expression was also higher for the TLR2-196 to-174 del variant carriers [117 ± 10 arbitrary unit(a.u.) vs 95 ± 4 a.u., P = 0.03]. However, for the TLR4-1607T/C polymorphism no significant difference was found for both m RNA(P = 0.56) and protein expression(P = 0.26).CONCLUSION: Our findings suggest that TLR2-196 to-174 del polymorphism increases TLR2 m RNA expression and is associated with higher CRC risk, indicating an important role in CRC genetic susceptibility. 展开更多
关键词 TOLL-LIKE RECEPTOR 2 TOLL-LIKE RECEPTOR 4 COLORECTAL cancer Protein EXPRESSION Gene EXPRESSION Genetic POLYMORPHISMS
暂未订购
Polymorphisms of folate metabolism genes in patients with cirrhosis and hepatocellular carcinoma
2
作者 Nathália Perpetua Peres Ana Lívia Silva Galbiatti-Dias +4 位作者 Marcia Maria Urbanin Castanhole-Nunes Renato Ferreira da Silva Erika Cristina Pavarino Eny Maria Goloni-Bertollo Mariangela Torreglosa Ruiz-Cintra 《World Journal of Hepatology》 CAS 2016年第29期1234-1243,共10页
AIM To evaluated the association of the risk factors and polymorphisms in MTHFR C677 T,MTHFR A1298 C,MTR A2756 G and MTRR A66 G genes.METHODS Patients with cirrhosis(n=116),hepatocellular carcinoma(HCC)(n=71)and contr... AIM To evaluated the association of the risk factors and polymorphisms in MTHFR C677 T,MTHFR A1298 C,MTR A2756 G and MTRR A66 G genes.METHODS Patients with cirrhosis(n=116),hepatocellular carcinoma(HCC)(n=71)and controls(n=356)were included.Polymerase chain reaction followed by enzymatic digestion and allelic discrimination technique real-time PCR techniques were used for analysis.MINITAB-14.0and SNPstats were utilized for statistical analysis.RESULTS Showed that age≥46 years(OR=10.31;95%CI:5.66-18.76;P<0.001)and smoking(OR=0.47;95%CI:0.28-0.78;P=0.003)were associated with cirrhosis.Age≥46 years(OR=16.36;95%CI:6.68-40.05;P<0.001)and alcohol habit(OR=2.01;95%CI:1.03-3.89;P=0.039)were associated with HCC.MTHFR A1298 C in codominant model(OR=3.37;95%CI:1.52-7.50;P=0.014),recessive model(OR=3.04;95%CI:1.43-6.47;P=0.0051)and additive model(OR=1.71;95%CI:1.16-2.52;P=0.0072)was associated with HCC,as well as MTR A2756 G in the additive model(OR=1.68;95%CI:1.01-2.77;P=0.047),and MTRR A66 G in the codominant model(OR=3.26;95%CI:1.54-6.87;P<0.001),dominant model(OR=2.55;95%CI:1.24-5.25;P=0.007)and overdominant model(OR=3.05;95%CI:1.66-5.62;P<0.001).MTR A2756 G in the additive model(OR=1.54;95%CI:1.02-2.33;P=0.042)and smokers who presented at least one polymorphic allele for MTRR A66G(OR=1.71;95%CI:0.77-3.82;P=0.0051)showed increased risk for cirrhosis.There was no association between clinical parameters and polymorphisms.CONCLUSION Age≥46 years,alcohol habit and MTR A2756 G,MTHFR A1298 C and MTRR A66 G polymorphisms are associated with an increased risk of HCC development;age≥46 years,tobacco habit and the MTR A2756 G polymorphism are associated with cirrhosis. 展开更多
关键词 POLYMORPHISM Folate metabolism Liver cirrhosis Hepatocellular carcinoma
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部